Tag: BMSN

XCHC, BMSN, ENTB & Extended Watchlist

Those of you who’ve been reading our newsletter for long enough, remember that we were one of the very first to start tracking the medical marijuana sector as a whole. Many of the plays contained in our first widespread account of marijuana stocks on October 16th even appeared prior to that report. Since that time, we’ve had several follow-up reports, covering close to a dozen different hemp stocks.

The X-Change Corporation XCHC

A few weeks ago we added XCHC to that group, and it seems we did so at just the right time. The week we brought it into the mix, the stock was trading as low as .0521, and has since hit a high .195, representing a profit of 274% in just three weeks. Though you might see others covering the stock presently, as regular monitors of the stock newsletter circuit, we were most assuredly the first to show up to the party.

Some of the other stocks in the cannabis arena have been seeing pullbacks of late, so we continue to monitor those for any upcoming bounce opportunities that we will certainly pass along, as always..
___

Bio-Matrix Scientific Group, Inc. BMSN
& Entest Biomedical, Inc. ENTB

After seeing recent runs from these two biotech stocks, both saw pullbacks, and subsequent rebounds to add to our recent win streak.

ENTB found support off of .0047 after running from .001-.0106

BMSN ran from .0003 to .0165, before pulling back to find support at .0071.

We’ll need to see both of those mentioned support levels hold moving forward, in order to continue to hold our interest. Consolidation periods can be good after multi-day runs like we’ve seen here. It is often caused by profit-takers exiting stage-left, and gives us a chance to see some new blood churn into the stocks, and laying the groundwork to give rise to the next upswing.
___

Extended Watchlist:
DVOX, OPXA, RPRX, 

BMSN, ENTB, BIOF, PEIX & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

We continue our coverage of BMSN this Tuesday morning following six consecutive sessions of positive moves for the stock.  Last Monday, we focused on BMSN, having already seen upwards of 2400% in gains from the stock to that point. From Monday’s low of .0075, to the high Friday at .015, we added another 100% rip to our resume’ of gains since we’ve been tracking BMSN.

Currently on the chart, we have a very favorable set-up. The 50DMA is approaching the 200DMA, setting up for a Golden Cross, which is something we always like to see.

While the chart is beginning to appear top-heavy, we have yet to observe any of the signs of the stock being overbought. We continue to see higher lows and higher highs being maintained. However it is at this point that we’ll exercise extreme caution, because as many other stocks in this position have taught us in the past, a wave of profit-taking could cause a sell-off at any time. At that point, we’d like to see a penny hold as support for BMSN to continue to hold our interest.

___

Entest BioMedical Inc. ENTB

We’ve been keeping ENTB in our extended watchlist consistently since January 15th. Shortly following that date we saw a low of .001. The stock has been gaining steadily since that time, and hit a high of .0077 on Friday. In exactly one month’s time, ENTB managed to increase 670% in value for us, and we couldn’t be more pleased.

It’s worthwhile to note that ENTB is under the same management as our previously mentioned winner, BMSN.

The chart is exhibiting similar pattern to BMSN as well, so we want to look out for the 50DMA to continue to curl up to the 200DMA toward a potential Golden Cross.

___

Side Note:

BIOF and PEIX, are our two ethanol plays that have continued to bring us solid gains. Friday’s session was no exception. PEIX traded in a range from .393-.469, a gain of 19%, while the range on BIOF was 5.678-6.84, a 20.5% jump.

___

Extended Watchlist:
PPHM, ODP, OMX, 

Marijuana Stocks Blazing to New Highs in 2013

Marijuana Stocks Blazing to New Highs in 2013

On Monday, we encouraged everyone to check out one of our recent marijuana stock reports, where we highlighted no less than ten plays in the up-and-coming sector. We feel like a broken record at this point, having pounded the table on these stocks for a very long time, but we won’t quit parroting ourselves until we’re sure everyone understands: If you ever asked yourself “what is the next ‘big thing’?”, this is it. Marijuana stocks are the next big thing, and we’ve done our absolute best to show everyone we believe just that. It has become clear to most lawmakers that the advantages to ending marijuana prohibition, particularly from a fiscal standpoint, far outweigh any alleged drawbacks. The Marijuana Stock Index has risen over 900%% since October, and it’s no coincidence. Just take a look at this article explaining how the marijuana industry is gearing up for a “legislative windfall” regarding the legal status of the now mostly-illicit substance.

This week, MWIP has thus far traded in a range from .0585-.12 gaining 105% If you take into the account the low since we first mentioned MWIP (.0024), our total cumulative gains have reached a staggering 4900% as of yesterday’s high.

ERBB hit a high of .0163 yesterday, which represents move of 104% from this week’s previous low of .008.

___

PureSafe Water Systems, Inc. PSWS

PSWS has been a successful new play on our watchlist, performing very well so far this week. It first appeared on our extended watchlist on Monday, when it was trading as low as .0049. Yesterday the stock closed at the high of day at .0075, a 53% gain from Monday’s low.

This morning’s PR:

PureSafe Water Systems, Inc. (OTCQB: PSWS) Announces The Signing Of An Exclusive Worldwide Sales And Marketing Agreement And An Engineering Package Agreement

PLAINVIEW, N.Y., Feb. 13, 2013 /PRNewswire via COMTEX/ — Leslie Kessler, CEO of PureSafe Water Systems, Inc. (OTCBB: PSWS) (OTCQB: PSWS), is pleased to announce the signing of strategic agreements with Global Equipment Marketing, Inc. (“GEM”) and Engineering Technologies Group, Inc. (“ETG”) of Hopkinton, MA.
___

Peregrine Pharmaceuticals, Inc. PPHM

Those of you who have followed us for long enough, know that PPHM is an old-time favorite of ours. We’ve tracked this play for the better part of a year now, and in that span, we’ve seen it make some stellar gains.

PPHM first began appearing in our watchlist in mid-August 2012, as it ran from 2.30-3.09, after which time it pulled back to 1.76, before skyrocketing as high as 5.50.

More recently, we’ve been looking for PPHM to challenge 2.78, a recent swing high, that represents the current main area of resistance on the chart. The company released favorable test results for its pancreatic cancer treatment this morning, so be sure to check this stock out if you have not  already done so.

This morning’s PPHM headline reads:

Peregrine Pharmaceuticals Announces Results From Phase II Clinical Trial of Bavituximab in Stage IV Pancreatic Cancer

Top-Line Results Demonstrate Signs of Anti-Tumor Activity; a 28% tumor response rate as opposed to the control group which posted a rate of just 13% These statistically significant results have the stock trading up 20% pre-market, so today should get interesting for PPHM.
___

Extended Watchlist:
ADCF, BMSN, GRPN, ZNGA, IGC,